PIMCO to Close and Liquidate Two Exchange-Traded Funds

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
79
PIMCO to Close and Liquidate Two Exchange-Traded Funds

NEWPORT BEACH, CA--(Marketwired - Feb 15, 2017) - PIMCO, a leading global investment management firm, will close and liquidate two exchange-traded funds.

PIMCO regularly reviews its product range to ensure it is meeting the requirements of clients in continuing to add value. Following careful consideration the decision has been made to close the following funds: PIMCO Diversified Income Active ETF ("DI") ( NYSE : DI ) and PIMCO Global Advantage® Inflation-Linked Bond Active ETF ("ILB") ( NYSE : ILB ).

The last day of trading on NYSE Arca, Inc. ("NYSE Arca") for each liquidating fund is expected to be March 31, 2017. Effective upon the close of business on March 31, 2017, DI and ILB will no longer accept orders for the purchase of Creation Units. Beginning when DI and ILB commence liquidation of their portfolios, the funds may not pursue their respective investment objectives or engage in normal business activities, except for the purposes of winding up their business and affairs, preserving the value of their assets, paying their liabilities, and distributing their remaining assets to shareholders.

The liquidation date for the funds will be on or about April 7, 2017 ("Liquidation Date"). There can be no assurance that there will be a market for the purchase or sale of fund shares during the time between the market close on March 31, 2017 and the Liquidation Date, because fund shares will not be traded on NYSE Arca.

In connection with the liquidations, any shares of DI or ILB outstanding on the Liquidation Date will be automatically redeemed as of the close of business on the Liquidation Date without the imposition of customary redemption transaction fees. In exchange for such shares, proceeds of the liquidation will be distributed in accordance with ordinary settlement times. Although the liquidations are not expected to be taxable events for DI and ILB, for taxable shareholders, the automatic redemption of shares of the funds on the Liquidation Date will generally be treated as a sale that may result in a gain or loss for federal income tax purposes. Instead of waiting until the Liquidation Date, a shareholder may voluntarily sell his or her shares on NYSE Arca (subject to customary transaction fees) until the market close on March 31, 2017.

For additional information about the liquidations, shareholders of DI and ILB may call 888-400-4ETF (888-400-4383).

About PIMCO 

PIMCO is a leading global investment management firm with offices in 11 countries throughout North America, Europe and Asia. Founded in 1971, PIMCO offers a wide range of innovative solutions to help millions of investors worldwide meet their needs. Our goal is to provide attractive returns while maintaining a strong culture of risk management and long-term discipline. PIMCO is the investment manager of the funds and is owned by Allianz S.E., a leading global diversified financial services provider.

Investors should consider the investment objectives, risks, charges and expenses of the funds carefully before investing. This and other information are contained in the respective fund's prospectus, which may be obtained by contacting your PIMCO representative. Please read the prospectus carefully before you invest.

ETFs are afforded certain exemptions from the Investment Company Act. The exemptions allow, among other things, for individual shares to trade on the secondary market. Individual shares cannot be directly purchased from or redeemed by the ETF. Purchases and redemptions directly with ETFs are only accomplished through Creation Unit aggregations or "baskets" of shares. Shares of an ETF are bought and sold at market price (not NAV). Brokerage commissions will reduce returns. Investment policies, management fees and other information can be found in the individual ETF's prospectus.

Premiums (when market price is above NAV) or discounts (when market price is below NAV) reflect the differences (expressed as a percentage) between the NAV and the Market Price of a fund on a given day, generally at the time the NAV is calculated. A discount or premium could be significant. Data in chart format displaying the frequency distribution of discounts and premiums of the Market Price against the NAV can be found for each fund at www.pimcoetfs.com .

Except for the historical information and discussions contained herein, statements contained in this news release constitute forward-looking statements. These statements may involve a number of risks, uncertainties and other factors that could cause actual results to differ materially, including the performance of financial markets, the investment performance of PIMCO's sponsored investment products and separately managed accounts, general economic conditions, future acquisitions, competitive conditions and government regulations, including changes in tax laws. Readers should carefully consider such factors. Further, such forward-looking statements speak only on the date at which such statements are made. PIMCO undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statement.

This material has been distributed for informational purposes only and should not be considered as investment advice or a recommendation of any particular security, strategy or investment product. No part of this material may be reproduced in any form, or referred to in any other publication, without express written permission. PIMCO is a trademark of Allianz Asset Management of America L.P. in the United States and throughout the world. PIMCO Investments LLC, distributor, 1633 Broadway, New York, NY 10019, is a company of PIMCO. ©2017, PIMCO.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 4

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Protecting Teeth: Insights from Endodontist Dr. Joubert

Updated Category News Views 7

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 7

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 5

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 4

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 3

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 5

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 1

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 4

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Farmland Partners Reports Third Quarter Growth and Dividends

Updated Category News Views 88

Strong Q3 Performance by Farmland Partners Farmland Partners (NYSE: FPI) has recently reported its impressive third-quarter earnings, highlighting a solid operational performance along with notable asset sales. CEO Luca Fabbri expressed confidence in the company's financial strategies, particularly in debt reduction and shareholder value return, including a special...

Continue Reading
Innovations in Nanotechnology Drug Delivery Transforming Healthcare

Updated Category News Views 317

Future Insights into the Nanotechnology Drug Delivery Market The global Nanotechnology Drug Delivery market is set for an impressive transition, with recent reports highlighting its growth from USD 95.7 billion in 2023 to a staggering USD 213.2 billion by 2032. This ambitious forecast is attributed to a robust CAGR of 9.3% during the period from 2024 to 2032. The driving...

Continue Reading
Loomis Integrates Peregrine Connect for Enhanced Efficiency

Updated Category News Views 152

Loomis Selects Low-Code Solution for Operational Excellence Loomis has made a significant decision to implement Peregrine Connect's no/low-code integration platform, a move aimed at enhancing operational efficiency and regulating costs across its extensive network. As one of the worldwide leaders in payment management systems, Loomis operates in numerous regions,...

Continue Reading
Sngular Names Chris Brown as U.S. Managing Director for Growth

Updated Category News Views 138

Sngular Names Chris Brown as U.S. Managing Director Veteran advanced technology executive Chris Brown has officially joined Sngular as the Managing Director for the United States. His mission is to spearhead U.S.-based growth and client execution strategies through a flexible delivery model that merges onshore leadership with near-shore and global teams. Chris Brown's...

Continue Reading
Sherwin-Williams Faces Challenges After Lowering Earnings Outlook

Updated Category News Views 125

Sherwin-Williams Adjusts Earnings Projections Following Q2 Results The Sherwin-Williams Company (NYSE: SHW) recently faced some challenges after reporting lower-than-expected second-quarter earnings. With adjusted earnings per share (EPS) of $3.38, the results fell short of Wall Street's predictions, which had estimated $3.81 per share. The company's quarterly revenue,...

Continue Reading